EviCure

Extracellular Vesicles-based Platform for the Treatment of Cancer

Active Seed Startup Rehovot Founded 2023-02

EviCure is developing a novel extracellular vesicle (EV)--based platform technology for cancer treatment. EviCure leverages AI capabilities and sophisticated human cancer disease models for in-depth comparative analyses of various stem cell subpopulations and secreted EVs to achieve robust and specific anti-tumor effects against a wide range of solid tumors…

SectorHealth Tech & Life Sciences
StageSeed
Total raised$700K
Employees5
Founded2023-02
HQRehovot
Confidence76
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCellsArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals